INTRODUCTION
Bovine leukemia virus (BLV) is a member of the genus Deltaretrovirus (subfamily Orthoretrovirinae, family Retroviridae) and is genetically related to human T-cell leukemia virus type 1 (HTLV-1) (Sagata et al., 1985) . HTLV-1 infects CD4
+ T-cells in humans, whereas BLV infects B-cells in cattle, but both viruses integrate into the genome as a provirus (Mirsky et al., 1996; Schwartz et al., 1994) . The majority of BLV-infected cattle exhibit no clinical symptoms, but a proportion of latently infected cattle develop a disease that is characterized by abnormal B-cell proliferation and B-cell lymphoma (BL) 5-10 years after infection. Epidemics of BLV infection have caused extensive economic losses in the dairy and beef industries (Gillet et al., 2007) because there is no effective immunization against this untreatable disease in cattle.
BLV-infected B-cells and BL cells frequently express IgM, IgG, CD5, CD11b, MHCII and CD25 (Gillet et al., 2007; Meirom et al., 1997) , but the markers expressed exclusively in BLV-infected B-cells that contain the provirus remain unknown. Thus, it is necessary to identify specific markers for BLV-infected B-cells to facilitate a better understanding of the kinetics of the excessive proliferation and transformation of B-cells.
It is not possible to identify all BLV-infected B-cells using an antibody specific to BLV antigen because BLV expression is observed rarely in vivo or in freshly isolated lymphocytes (Asquith et al., 2005; Gillet et al., 2007; Hanon et al., 2000; Powers & Radke, 1992) . However, short-term ex vivo cultivation at 37 u C leads to viral antigen expression, such as gp51 and p24, which are the viral membrane protein and core protein, respectively. Florins et al. (2012) reported that viral antigen expression caused high in vivo death rates of Bcells when BLV-infected lymphocytes were cultivated and transplanted into BLV-infected donor cattle. These data suggest that the silenced expression of viral antigens appears to be a strategy for reducing immunogenicity, evading immune surveillance and promoting efficient propagation in BLV-infected cattle.
Previous reports based on the detection of BLV antigens by flow cytometry and microscopy after ex vivo cultivation demonstrated that some, but not all, B-cells expressed BLV antigens (Fulton et al., 2006; Gillet et al., 2007; Ikebuchi et al., 2013) . Moreover, a silent provirus was integrated into B-cell tumours isolated from BLV-infected sheep and the cell lines derived from these tumours (Merimi et al., 2007a, b; Van den Broeke et al., 1988) . These reports suggested that 'BLV-silencing' B-cells are present among lymphocytes in infected cattle. Thus, it is hypothesized that at least two subsets are present among B-cells with genomes that incorporate BLV provirus: 'BLV-expressing' B-cells that can transmit BLV to BLV-uninfected cells, which may be detected by the immune surveillance system to activate immune cells, thereby leading to their eradication, and 'BLV-silencing' B-cells, which can proliferate without being attacked by immune cells (Gillet et al., 2007) .
In the present study, we investigated the expression of surface markers and viral antigens on the B-cells of BLVinfected cattle to identify markers that may distinguish BLVexpressing B-cells from BLV-silencing B-cells. We found that IgM high B-cells were likely to express BLV antigen, whereas IgM low B-cells were not, although the provirus loads in both subsets were similar. Thus, we performed gene expression profiling and several cellular function analyses in both subsets, and speculate on the functional differences between IgM high and IgM low B-cells in vivo.
RESULTS
Surface IgM (sIgM) expression is increased in Bcells isolated from BLV-infected cattle First, we analysed the expression levels of sIgM and B-cellassociated surface markers CD19-like (bovine WC4) and CD21-like, which are molecules analogous to human CD19 and CD21, respectively (Mukwedeya et al., 1993; Naessens et al., 1997) , in B-cells isolated from BLV-infected cattle at different disease stages. The percentages of IgM + B-cells among PBMCs increased in BLV-infected cattle as the number of lymphocytes increased in the blood (Fig. 1a and S1a available in the online Supplementary Material). In BLV-uninfected cattle, IgM + B-cells comprised up to 50 % of PBMCs. The mean fluorescence index (MFI) of sIgM expression was also higher in IgM + B-cells from BLVinfected cattle compared with BLV-uninfected cattle (Fig.  1b) . In contrast, dual staining with anti-IgM and anti-CD19-like or anti-CD21-like showed that the proportions of both CD19-like + cells and CD21-like + cells as well as the MFI of CD19-like and CD21-like expression in IgM + B-cells from BLV-infected cattle were lower than those from BLVuninfected cattle (Figs 1c and S1b). The increased IgM expression and decreased CD19-like and CD21-like expression in B-cells were correlated with the proportions of IgM + B-cells in PBMCs (Fig. 1d) Thus, BLV-expressing and BLV-silencing B-cells could be roughly discriminated based on differences in the sIgM expression levels.
IgM and WC4 stimulation upregulate gp51 expression
To identify whether sIgM and CD19-like molecules have a role in the expression of BLV antigens, we measured the changes in BLV gp51 expression in B-cells treated with anti-IgM, anti-WC4 (CD19-like) or phosphatidylinositol 3-kinase (PI3-kinase) inhibitors, which inhibit the signalling associated with CD19 (So & Fruman, 2012) . Anti-IgM treatment upregulated gp51 expression in B-cells (Fig.  S3a ), which agreed with the results of a previous study (Kerkhofs et al., 1996) . There was no difference in the gp51 expression levels of B-cells treated with goat IgG or PBS in some samples (data not shown). The percentages of gp51 + B-cells were increased by anti-WC4 treatment compared with mouse IgG1 treatment (Fig. S3b ), but they were decreased by treatment with two types of PI3-kinase inhibitor (Fig. S3c) . Moreover, the treatment of LY294002 which is a more specific PI3-kinase inhibitor than Wortmannin PI3-kinase abolished the effect of anti-WC4 treatment (Fig. S3d) (Fig. 3a) , although IgM high B-cells were more likely to express BLV antigen (Fig. 2b, c) .
GLUT-1 and neuropilin-1 have been identified as the cellular receptors required for HTLV-1 entry (Ghez et al., PBMCs isolated from BLV-infected and BLV-uninfected cattle (n524 and 18, respectively). The lines in the correlation diagrams indicate the approximation straight lines for data from BLV-infected cattle, which were generated by fitted linear regression (a, d). The correlation statistics were analysed using Spearman's rank correlation test. Each line of data for BLVinfected and BLV-uninfected cattle indicates the mean values in each group (b, c, e) . Statistical comparisons between the BLVinfected and BLV-uninfected cattle were performed using a Mann-Whitney test or a one-way ANOVA with Tukey's test. Differences were considered statistically significant at P,0.05 (**P,0.01).
2006; Manel et al., 2003) . The receptors required for BLV entry remain unidentified, but staining using BLV envelope-Ig fusion protein (BLV-env-Ig) facilitates analysis of the expression of BLV-binding receptors, which are expected to be BLV receptors (Lavanya et al., 2008 (Fig. 4a) . Furthermore, the responsiveness to WC4 stimulation was almost the same in all B-cell subsets.
Previous studies have shown that BLV infection in sheep protected their PBMCs from ex vivo apoptosis (Dequiedt et al., 1997) and that human CD21 low B-cells were sensitive to apoptosis (Charles et al., 2011; Isnardi et al., 2010) . Thus, we investigated the susceptibility of B-cells from BLV-infected cattle to cell death, and found that they expressed lower levels of CD21-like than B-cells from BLVuninfected cattle (Fig. 1c) B-cells than in IgM high B-cells from BLV-infected and BLVuninfected cattle (Figs 4b and S5b) . Moreover, IgM low Bcells from BLV-infected cattle were more susceptible to cell death than those from BLV-uninfected cattle.
In our previous study, we showed that the proportion of PD-L1
+ B-cells [programmed death ligand 1 (PD-L1) is one of the immunoinhibitory molecules that induced Tcell anergy in cattle] was higher in advanced-disease-stage BLV-infected cattle than in BLV-uninfected cattle (Ikebuchi et al., 2011) . In the present study, the percentages of PD-L1 Most IgM low B-cells appeared to be BLV-silencing cells, which were able to evade immune surveillance (Gillet et al., 2007) . In fact, p24 antigen was expressed by 29.3 % of IgM low B-cells (mean value in Fig. 2c ), but only 7.1 % of IgM low B-cells expressed gp51 antigen. The expression of gp51 is essential for cell-to-cell infection because of the unstable nature of BLV particles outside the cell membrane (Derse et al., 2001; Gatot et al., 1998; Igakura et al., 2003; Johnston et al., 1996) . Thus, p24
+ IgM low B-cells appear to be an inefficient population for the expansion of BLV infection. In future research, it will be necessary to identify markers other than sIgM to facilitate studies of the mechanism of BLV silencing because it is still difficult to distinguish strictly BLV-expressing cells from BLV-silencing cells based on the detection of sIgM expression.
The increased number of IgM high B-cells in blood from BLV-infected cattle could be explained by an increase in the production of immature B-cells in primary lymphoid organs after BLV infection. Many studies have detected high sIgM expression levels in the immature B-cells that emigrate from ileal Peyer's patches in sheep (Griebel et al., 1992; Yasuda et al., 2006) and in immature transitional type 1 B-cells in mice models (Cambier et al., 2007; Teague et al., 2007) . Furthermore, Fulton et al. (2006) detected the emergence of IgM high B-cells only in the blood and not in the efferent lymph after BLV infection in sheep. These reports suggest that the increase in IgM high B-cells in the blood of BLV-infected cattle may be attributable to nonrecirculating immature B-cells derived from either bone marrow or Peyer's patches, which are the primary lymphoid organs responsible for B-cell development and B-cell diversity in cattle and sheep (Yasuda et al., 2006) . In HTLV-1 infection, immature thymocytes are the targets for infection, and the emergence of malignant clones in the thymus may be selected over time in HTLV-1-infected patients (Feuer et al., 1996; Hasegawa et al., 2006) . Thus, the progenitor cells of B-cells could be infected with BLV in the primary lymphoid organs. Further studies of the mechanism of bovine B-cell development are required to test this hypothesis.
CD19 expression by B-cells is essential for inducing the germinal centre (GC) reaction in LNs after the recognition of a cognate antigen by follicular dendritic cells (Depoil et al., 2008) . The GC reaction is considered to be an important step in the induction of BL by Epstein-Barr virus (Küppers, 2003) . Furthermore, CD19 promotes oncogene expression and tumour growth in human BL, where a longer survival period was observed in patients with low CD19 expression levels (Chung et al., 2012) . In the present study, high expression levels of CD19-like molecule were observed in IgM low B-cells among the lymphocytes that were freshly isolated from BLV-infected cattle. Thus, IgM low B-cells that strongly express CD19-like may have a tendency to expand and develop into lymphoma cells through the GC reaction.
The results obtained in this study demonstrated that the IgM high and IgM low B-cell subsets have an inherent capacity to survive in vivo (Table S4 ). The proportions of live and dead cells in cultivated PBMCs also suggest that IgM high Bcells exhibit superior survival. However, a capacity for in vivo expansion was also detected in IgM low B-cells. The higher expression levels of PD-L1 and lower expression levels of gp51 in this subset are related to immune escape from virus-specific T-cells. Higher expression levels of CD19-like molecule also appear to favour antigen recognition and cellular activation during antigen presentation by dendritic cells (Depoil et al., 2008) . Moreover, the expression levels of some proto-oncogenes (MafB, Jun, Fos, FosB, Frat1 and Fyn) were increased in IgM low B-cells, whereas IgM high BL cells were not observed in LNs from any of the 14 BLV-infected cattle with BL, thereby raising the possibility that either IgM low B-cells or clones derived from these cells are more likely to become neoplastic Bcells compared with IgM high B-cells. This possibility was also supported by the microarray data, where chemokine genes and genes associated with chemotaxis, such as CCL3, CCL4, IL-8 and CCR1, were upregulated in IgM low B-cells. In chronic lymphocytic leukaemia (CLL) patients, the recirculation and spread of CLL cells in the body are preferentially induced by the CCL3 and CCR1 system (Trentin et al., 2004) . Moreover, CCL3, CCL4 and IL-8 derived from lymphoma cells induce the homing of accessory cells, which creates a supportive microenvironment for the maintenance and expansion of neoplastic cells (Burger, 2010 In contrast to BCR expression by BLV-infected B-cells, the expression level of the T-cell receptor, CD3, in HTLV-1-infected T-cells decreased gradually with disease progression. Progressive losses of CD3 expression have been observed in both HTLV-1-infected cell lines and CD4
+ Tcells from HTLV-1-infected patients (Akl et al., 2007; Kobayashi et al., 2013) . A study using CD4 + T-cell lines experimentally infected with HTLV-1 also showed that CD3 high and CD3 low T-cells had the same capacity to express the HTLV-1 core protein (Willard-Gallo et al., 2001) . Moreover, despite the structural and functional homology between HTLV-1 and BLV, treatment with a calcium ionophore reduced viral expression in HTLV-1-infected T-cells (Copeland et al., 1994) , whereas it was upregulated in BLV-infected B-cells (Kerkhofs et al., 1996) . Previous reports and the results obtained in the present study suggest that HTLV-1-infected T-cells and BLVinfected B-cells may use different signalling pathways and strategies to express viral antigens and to expand their infection to uninfected cells.
The present study showed that the number of IgM high Bcells increased in the blood of BLV-infected cattle and that they were likely to express BLV antigen after ex vivo cultivation, suggesting their role as sources of BLV infection. By contrast, IgM low B-cells included a high proportion of BLV-silencing cells, which expressed high levels of some proto-oncogenes. To our knowledge, this is the first study to investigate IgM high and IgM low B-cells in BLV-infected cattle. Our analyses of these two B-cell subsets provide insights into the mechanisms of viral silencing, the target cells of antiviral treatments or antitumour therapy, and disease progression and transformation during BLV infection.
METHODS
Ethics statement. All animal experiments were conducted in accordance with the Guidelines for Proper Conduct of Animal Experiments (Science Council of Japan) and all protocols were approved by the Institutional Animal Care and Use Committee of Hokkaido University, Japan (approval no. 11-0059). Informed consent was obtained from clinical veterinarians and farmers before sample collection.
Samples from cattle, BLV diagnosis and cell preparation. In total, 166 blood samples were obtained from Holstein-Friesian and Japanese Black breed (BLV-infected: n5117, BLV-uninfected: n549) bred on several farms in Japan. All animals had been diagnosed with BLV infection and BL by nested PCR and flow cytometry as described previously (Ikebuchi et al., 2011 (Ikebuchi et al., , 2013 . Enlarged LNs and blood samples from 14 BLV-infected cattle with BL were provided by several farms and veterinarians. The number of lymphocytes in the blood was counted using an MEK-6450 Celltaca (Nihon Kohden). PBMCs were purified from heparinized blood by density-gradient centrifugation on Percoll (GE Healthcare). Expression of recombinant BLV-env-Ig. Soluble BLV-env-Ig was expressed in CHO-DG44 cells (provided by Dr Y. Suzuki, Hokkaido University, Japan) that were stably transfected with pCAGGS (provided by Dr J. Miyazaki, Osaka University, Japan) (Niwa et al., 1991) , which encoded a mouse CD150 signal sequence, the extracellular region of BLV env and the Fc fragment of rabbit IgG, as described previously (Arase et al., 2002; Ikebuchi et al., 2013) . The concentration of BLV-env-Ig in supernatants was measured using a Rabbit IgG ELISA Quantification Set (Bethyl Laboratories).
Flow cytometry. To analyse the expression levels of B-cell markers, BLV antigens, BLV-binding receptors and PD-L1 by flow cytometry, we used the following antibodies and recombinant protein: antibovine IgM (clone BIG73A), anti-WC4 (CC55; CD19-like), anti-B-B7 (clone GB25A; CD21-like; VMRD), anti-BLV-gp51 (BLV1; VMRD), anti-BLV-p24 (BLV3; VMRD), BLV-env-Ig and anti-bovine PD-L1 (clone 4G12) (Ikebuchi et al., 2014) . To induce BLV antigen expression in BLV-infected cells, PBMCs were cultivated overnight in RPMI 1640 (Sigma-Aldrich), which was supplemented with 10 % FBS (Cell Culture Technologies) and a mixture of 2 mmol Lglutamine, 100 U penicillin ml 21 and 100 mg streptomycin ml 21 (Life Technologies; complete RPMI 1640). Detailed information about staining is provided in the Supplementary Methods.
Real-time PCR. IgM high and IgM low B-cells were isolated from PBMCs, which were cultivated overnight to express BLV antigens, as described above. To measure the provirus load, the total cellular DNA was purified from IgM high and IgM low B-cells with a Nucleospin Tissue XS (Macherey Nagel). The provirus and b-globin gene (internal control) were amplified by quantitative real-time PCR with SYBR Premix DimerEraser (Takara-Bio), as described previously (Ikebuchi et al., 2013; So & Fruman, 2012 Microarray analysis. Microarray analysis was performed using a bovine oligo DNA microarray (Agilent Technologies) in the DNA Tip Laboratory (Kanagawa, Japan). PBMCs were isolated from three BLV-infected cattle and IgM high and IgM low B-cells were sorted from cultivated PBMCs to purify the total RNA using an RNeasy Plus Mini kit (Qiagen). cDNA synthesis, cRNA transcription, labelling, hybridization, scanning and data analysis were performed according to the manufacturer's instructions. Gene ontology analysis of the genes identified was performed using GeneSpring GX 11 (Agilent Technologies). More detailed information is provided in the Supplementary Methods. The microarray data were deposited in Gene Expression Omnibus (GSE52388; http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?token=ytqneqagzbstfcp&acc=GSE52388). To confirm the reliability of the microarray data, the expression levels of some genes (MafB, Jun, Fos, FosB, Frat1, Fyn, Ccl3, Ccl4, IL-8 and Ccr1) were measured using RNA samples from nine BLV-infected cattle by quantitative real-time PCR. cDNA was synthesized with Moloney murine leukemia virus reverse transcriptase (Takara-Bio) and real-time PCR was performed with SYBR Premix DimerEraser.
Detection of live and dead cells. PBMCs were cultivated overnight in complete RPMI 1640 and stained with annexin V-FITC (Beckman Coulter) and 7-aminoactinomycin D (7-AAD; BD Biosciences), as described previously (Ikebuchi et al., 2013 
